Bandingkan Harga & Kinerja Panca Mitra Multiperdana Tbk. (PMMP) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Panca Mitra Multiperdana Tbk. dan Organon Pharma Indonesia Tbk.: Panca Mitra Multiperdana Tbk. diperdagangkan di Rp50 (kapitalisasi pasar 129,42 M), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Panca Mitra Multiperdana Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| PMMP | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 129,42 M | 104,4 M |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Panca Mitra Multiperdana Tbk.
PT Panca Mitra Multiperdana Tbk (the Company) was established in Jakarta based on Notarial Deed No. 52 of Buntario Tigris Darmawa Ng, S.H., S.E., Candidate Notary, dated August 8, 1997. The Company commenced its commercial activity in 1997. The Company’s immediate parent company is PT Tiga Makin Jaya, which is ultimately owned by Soesilo Soebardjo.
Selengkapnya di halaman PMMP →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
